David A. Jaffray, BSc, PhD - MD Anderson Cancer Center
Jan 24, 2023 · Dr. Jaffray is world-renowned for pioneering state-of-the-art image-guided radiation therapy, advancing the science and practice in medical physics, and for international …
David Jaffray - Wikipedia
David A. Jaffray is a Canadian medical physicist and Senior Scientist in the Division of Biophysics and Bioimaging at the Ontario Cancer Institute. He is also a professor and Vice Chair in the …
David Jaffray - MD Anderson Cancer Center
Clinical Benefit from Docetaxel +/− Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and …
David A Jaffray's research works | University of Texas MD Anderson ...
Radiation therapy (RT) is an essential component of effective cancer care and is used across nearly all cancer types. The delivery of RT is becoming more precise through rapid advances in...
David Jaffray, Ph.D., Named Chief Technology and Digital Officer
May 21, 2019 · For more than two decades, Jaffray’s peer-reviewed and industry-sponsored research has focused on the development and application of image-guided radiation therapy, …
David Jaffray, PhD, Named Chief Technology and Digital
May 22, 2019 · For more than two decades, Jaffray’s peer-reviewed and industry-sponsored research has focused on the development and application of image-guided radiation therapy, …
The ultra-fast cancer treatments which could replace conventional ...
4 days ago · A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional radiotherapy. It also takes less than a second.
Intra-treatment hypoxia directed major radiation de-escalation …
May 29, 2024 · We now report the results of a successor multi-center phase II trial of hypoxia-directed de-escalated chemoradiotherapy without surgery for HPV+OPC. Methods: HPV+ …
Short-term neoadjuvant androgen deprivation therapy and …
Feb 1, 2008 · Purpose: Radiation Therapy Oncology Group (RTOG) 8610 was the first phase III randomized trial to evaluate neoadjuvant androgen deprivation therapy (ADT) in combination …
Phase I study of adavosertib with radiation therapy and …
The Adult Brain Tumor Consortium performed a phase I study of adavosertib, radiation (RT) and temozolomide (TMZ) in newly diagnosed glioblastoma (GBM) as well as a surgical window of …
- Some results have been removed